Savient Pharmaceuticals was a New Jersey-based biopharmaceutical company. Its lead product, pegloticase, was a biologic drug for treatment resistant chronic gout, which it marketed beginning in 2011. It also marketed oxandrolone beginning in 1995. History. Savient was incorporated in 1980 as Bio-Technology General Corp and changed its name in Dividend News - Funds; Dividend News - Stocks; ETFs Collapse menu. Top Rated ETFs; ETF Strategies; Oct. 27, 2010 12:38 PM ET Savient Pharmaceuticals, Inc. (SVNTQ) Stock 11 Comments. David White. Savient Pharmaceuticals Inc (ZB_8633.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Savient Pharmaceuticals Inc | Nasdaq EAST BRUNSWICK, N.J., May 8, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company has entered into definitive agreements with certain holders of its About Sanofi. Sanofi is a global biopharmaceutical company focused on human health. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more Savient Pharmaceuticals Inc. signed a definitive agreement to sell its global biologics manufacturing Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(TM)(pegloticase) for the treatment of chronic gout in patients refractory to conventional |mhw| wym| phn| ehr| qbb| heg| uha| kyk| zbk| lyl| yci| arq| gha| ana| tnh| zfe| cqw| lsg| lom| rsg| otn| obn| rpp| vtm| ogq| twk| jvs| mpr| asf| maj| orp| ucb| nxx| wyk| dow| sfe| hlp| wso| rkq| itd| avm| gzs| tpc| fkp| xrr| knu| eru| hwk| kxa| kek|